Viatris said it would pay between $27.5 million to $40 million annually toward state and local opioid initiatives, but maintained that the settlement does not constitute an admission of wrongdoing ...

Viatris to pay up to $335 million over nine years to settle opioid claims nationwide. The company has accrued $270 million for potential resolution, noted in its 2024 10-K filing. Markets are ...

Viatris (NASDAQ:VTRS) has agreed to pay up to a maximum of $335M as part of a nationwide settlement to resolve opioid-related claims. The amount consists of annual payments over a nine-year period ...

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...

Viatris to Pay up to $335 Million to Resolve Opioid-Related Claims (Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve ...